logo
15:53 Dec 05

Par Drugs & Chemicals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
96.84
+8.99 (+10.23%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Par Drugs & Chemicals Ltd. Financials

Par Drugs & Chemicals Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
96.84
+8.99 (+10.23%)
15:53 Dec 05
Quality
image/svg+xml

55/100
High Financial Strength

Valuation
image/svg+xml

54/100
Affordable Valuation

Technical

32/100
Technically Bearish

Strength

8

Weakness

7

Opportunity

0

Threats

0

13.49 %

ROE %

11.18 %

ROA %

7.87

EPS

80.44

BVPS

0.00 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
75.07 95.75 95.64 100.97 104.42
Operating Expenses +
58.83 77.55 72.82 81.47 85.57
Raw Material
29.61 41.03 33.32 39.41 41.31
Increase Decrease in Cost
-0.79 -0.7 0.47 -1.28 0.66
Other Manufacturing Expense
21.04 26.08 25.09 0 0
Employee Cost
4.1 4.89 5.5 5.85 6.01
Miscellaneous Expenses
4.87 6.25 8.44 37.49 37.59
Operating Profit
16.24 18.2 22.82 19.5 18.85
Other Income
0.18 0.24 0.24 2.15 3.92
Depreciation
3.28 3.23 3.44 3.65 3.64
Interest
0.45 0.13 0.11 0.08 0.08
Profit before tax and exceptio..
12.7 15.08 19.52 17.92 19.05
Exceptional Items
0 0 0 0 0
PBT
12.7 15.08 19.52 17.92 19.05
Provision for Taxation
3.49 3.75 5.02 4.56 4.86
Net Profit
9.21 11.33 14.5 13.36 14.16
NET Profit after MI
0 0 0 0 0
EPS
7.49 9.21 11.78 10.86 11.5
Operating Profit Margin (%)
21.63 19.01 23.86 19.31 18.05
Net Profit Margin (%)
12.27 11.83 15.16 13.23 13.56

Par Drugs & Chemicals Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
Promoter 73.40 73.40 73.40 73.40 73.40 74.20
FII 0.00 0.00 0.00 0.00 0.10 0.30
Public 0.00 0.00 0.00 0.00 0.00 0.00
Others 26.60 26.60 26.60 26.60 26.50 25.50
Shareholder Shares Holding %
Research 360 logo
Download Our App On: